Document is current
Any future updates will be listed below
-
Authors
Young, Su Ling https://orcid.org/0000-0003-2992-5990
Gazzard, Gus https://orcid.org/0000-0003-1982-5005
- License Information
-
More Information
Article History
Received: 21 December 2024
Revised: 10 August 2025
Accepted: 12 September 2025
First Online: 25 September 2025
Competing interests
: Young has no conflicts of interest to declare. Gazzard reported personal fees from Alcon Laboratories, Allergan/AbbVie, Lumenis, Lumibird/Quantel/Ellex, Zeiss and personal fees from Ciliatech, Elios Vision, Genentech/Roche, Glaukos, Haag-Streit Group, Iantrek, iStar Medical, Oertli, Reichert, Ripple Therapeutics, Santen, Sight Sciences, Thea, and Vialase and serving as a member of organising or meeting programme committees for American Society of Cataract and Refractive Surgery, British Council for Prevention of Blindness, European Glaucoma Society, European Society Of Cataract & Refractive Surgeons, European Vision Institute Clinical Research Network, Glaucoma-UK, Moorfields NHS Trust, National Institute for Health and Care Excellence, Royal College of Ophthalmologists UK and Éire Glaucoma Society, University College London, and World Glaucoma Congress outside the submitted work.
